FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a plasmid construct based on vector pSK-T7 and used for in vitro synthesis of guide RNA against a fragment of sequence of 51st exon of the Dmd gene, as well as to a method for producing a line of mice containing mutation in 51st exon.
EFFECT: invention enables to create a line of genetically modified mice for simulating Duchenne muscular dystrophy and developing therapeutic approaches.
3 cl, 11 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING GENETICALLY MODIFIED LABORATORY ANIMALS WITH NULL ALLELE OF P2rx3 GENE | 2022 |
|
RU2805173C1 |
| METHOD OF PRODUCING GENETICALLY MODIFIED MICE EXPRESSING HUMAN ANTITHROMBIN III MINIGENE USING MICROINJECTIONS OF TELN-LINEARIZED DNA FRAGMENT | 2022 |
|
RU2806568C1 |
| SYSTEM OF TARGETED SPLICING CHANGES IN MARK2 GENE | 2023 |
|
RU2810907C1 |
| METHOD OF OBTAINING A KNOCKOUT OF THE CD209 GENE IN BOS TAURUS EMBRYOS BY TRANSDUCING ZYGOTES WITH ADENO-ASSOCIATED VIRUSES ENCODING SACAS9 AND THE CORRESPONDING GUIDE RNA | 2022 |
|
RU2800917C1 |
| METHOD FOR DETECTING GBSSI GENE EDITING EVENTS IN CEREALS USING SET OF OLIGONUCLEOTIDE SEQUENCES | 2023 |
|
RU2817377C1 |
| METHOD OF OBTAINING GENETICALLY MODIFIED LABORATORY ANIMALS WITH INDUCIBLE SYSTEMIC AND TISSUE-SPECIFIC EXPRESSION OF HUMAN CYCLOPHILIN A | 2022 |
|
RU2800264C1 |
| T7 PHAGE DNA-DEPENDENT RNA-POLYMERASE ENZYME PRODUCER STRAIN | 2022 |
|
RU2825469C2 |
| NUCLEOTIDE SEQUENCE CODING LYTICASE ENZYME, AND PANEL OF OLIGONUCLEOTIDES FOR OBTAINING SYNTHETIC NUCLEOTIDE SEQUENCE OF LYTICASE GENE | 2023 |
|
RU2826150C1 |
| METHOD FOR GENOTYPING NEISSERIA GONORRHOEAE ISOLATES ON BIOLOGICAL MICROCHIP | 2023 |
|
RU2816767C1 |
| METHOD OF IDENTIFICATION OF SINGLE-NUCLEOTIDE POLYMORPHISMS IN MULTICOPY GENOME LOCUS USING LOOP-POLYMERASE CHAIN REACTION METHOD WITH SUBSEQUENT HYBRIDIZATION ON BIOLOGICAL MICROCHIP | 2022 |
|
RU2809184C1 |
